190 related articles for article (PubMed ID: 9846980)
21. Serine protease inhibitors modulate smoke-induced chemokine release from human lung fibroblasts.
Numanami H; Koyama S; Nelson DK; Hoyt JC; Freels JL; Habib MP; Amano J; Haniuda M; Sato E; Robbins RA
Am J Respir Cell Mol Biol; 2003 Nov; 29(5):613-9. PubMed ID: 12738688
[TBL] [Abstract][Full Text] [Related]
22. Monocyte chemotactic factors released from type II pneumocyte-like cells in response to TNF-alpha and IL-1alpha.
Koyama S; Sato E; Nomura H; Kubo K; Miura M; Yamashita T; Nagai S; Izumi T
Eur Respir J; 1999 Apr; 13(4):820-8. PubMed ID: 10362047
[TBL] [Abstract][Full Text] [Related]
23. Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke.
Koyama S; Rennard SI; Leikauf GD; Ertl RF; Robbins RA
Exp Lung Res; 1996; 22(1):1-19. PubMed ID: 8838132
[TBL] [Abstract][Full Text] [Related]
24. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity.
Sato E; Koyama S; Okubo Y; Kubo K; Sekiguchi M
Am J Physiol; 1998 Jun; 274(6):L970-9. PubMed ID: 9609736
[TBL] [Abstract][Full Text] [Related]
25. Bronchial epithelial cells release monocyte chemotactic activity in response to smoke and endotoxin.
Koyama S; Rennard SI; Leikauf GD; Robbins RA
J Immunol; 1991 Aug; 147(3):972-9. PubMed ID: 1861084
[TBL] [Abstract][Full Text] [Related]
26. Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro.
Numanami H; Koyama S; Sato E; Haniuda M; Nelson DK; Hoyt JC; Freels JL; Habib MP; Robbins RA
Am J Physiol Lung Cell Mol Physiol; 2003 May; 284(5):L882-90. PubMed ID: 12676771
[TBL] [Abstract][Full Text] [Related]
27. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
28. Identification of leukotriene B4 as the neutrophil chemotactic factor released by antigen challenge from passively sensitized guinea pig lungs.
Atkins PC; Valenzano M; Goetzl EJ; Ratnoff WD; Graziano FM; Zweiman B
J Allergy Clin Immunol; 1989 Jan; 83(1):136-43. PubMed ID: 2536412
[TBL] [Abstract][Full Text] [Related]
29. Eosinophil chemotactic activity in bronchoalveolar lavage fluid obtained from Toxocara canis-infected rats.
Okada K; Fujimoto K; Kubo K; Sekiguchi M; Sugane K
Clin Immunol Immunopathol; 1996 Mar; 78(3):256-62. PubMed ID: 8605701
[TBL] [Abstract][Full Text] [Related]
30. Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity.
Koyama S; Sato E; Nomura H; Kubo K; Nagai S; Izumi T
J Appl Physiol (1985); 1998 May; 84(5):1528-34. PubMed ID: 9572795
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of MIP-1alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites.
Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA
J Lab Clin Med; 2000 Feb; 135(2):161-9. PubMed ID: 10695661
[TBL] [Abstract][Full Text] [Related]
32. IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells.
Nakamura H; Luster AD; Tateno H; Jedrzkiewicz S; Tamura G; Haley KJ; Garcia-Zepeda EA; Yamaguchi K; Lilly CM
Am J Physiol Lung Cell Mol Physiol; 2001 Nov; 281(5):L1288-302. PubMed ID: 11597922
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1.
Helset E; Sildnes T; Konopski ZS
Mediators Inflamm; 1994; 3(2):155-60. PubMed ID: 18472935
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.
Hilger RA; Köller M; König W
Inflammation; 1996 Feb; 20(1):57-70. PubMed ID: 8926049
[TBL] [Abstract][Full Text] [Related]
35. Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.
DiPersio JF; Billing P; Williams R; Gasson JC
J Immunol; 1988 Jun; 140(12):4315-22. PubMed ID: 2453577
[TBL] [Abstract][Full Text] [Related]
36. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
38. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms.
Thakur A; Willcox MD; Stapleton F
J Clin Immunol; 1998 Jan; 18(1):61-70. PubMed ID: 9475355
[TBL] [Abstract][Full Text] [Related]
39. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
40. Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.
Rankin JA; Sylvester I; Smith S; Yoshimura T; Leonard EJ
J Clin Invest; 1990 Nov; 86(5):1556-64. PubMed ID: 2173722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
